Sanofi | SAN - Pasivo Circulante





Pasivo Circulante Cambio Fecha
AbbVie USD 41.64B 458M 2026-06
Aena EUR 2.71B 256.31M 2026-09
Alcon AG USD 3.17B 163M 2026-06
Almirall EUR 323.65M 26.99M 2026-06
Amarin USD 175.14M 10.94M 2026-09
Amgen USD 25.5B 547M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Bayer EUR 32.27B 1.19B 2026-06
Biogen USD 3.9B 18.7M 2026-09
BMW EUR 81.23B 492M 2026-03
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Eli Lilly USD 47B 745M 2026-09
Essilor EUR 12.64B 490M 2026-06
Fresenius EUR 9.07B 468M 2026-06
Fresenius Medical Care EUR 7.18B 448.03M 2026-06
Genmab DKK 1.14B 38M 2026-06
Gilead Sciences USD 11.02B 1.54B 2026-06
GlaxoSmithKline GBP 20.72B 814M 2026-09
GRIFOLS EUR 2.24B 112M 2026-06
Hikma Pharmaceutical USD 1.45B 603M 2025-12
J&J USD 55.46B 562M 2026-09
Lakefront Biotherapeutics EUR 70.32M 30.1M 2026-06
Lonza CHF 3.57B 421M 2025-12
Mercedes-Benz AG EUR 75.14B 3.92B 2026-09
Merck EUR 8.12B 1.22B 2026-06
Merck USD 27.73B 786M 2026-06
Novartis USD 31.75B 374M 2026-06
Novo Nordisk DKK 239.08B 13.92B 2026-06
Orion EUR 491.8M 37.3M 2026-09
Pfizer USD 32.65B 1.7B 2026-06
Philips EUR 7.42B 8M 2026-06
Recordati EUR 1.4B 30.88M 2026-06
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 31.93B 1.92B 2026-06
Sanofi EUR 30.01B 1.66B 2026-03
SAP EUR 19.11B 624M 2026-09
UCB EUR 4.4B 470M 2025-12
Vinci EUR 59.23B 1.14B 2026-06
Volkswagen EUR 244.68B 7.37B 2026-09